Kim et al. showed that ginsenoside Rh2 and Rg3 can reduce the increase in TNF-α and IL-4 mRNA expression induced by TNCB, exerting anti-inflammatory effects and inhibiting TNF-α mRNA expression in vivo, thus effectively treating AD in mice [54]. Here, TNF is linked to Alzheimer disease.